Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06159335 · ClinicalTrials.gov registry record · Phase 3
18F-FLUC PET/MR in Patients With Brain Mets
A Phase 3 study of Radiation Therapy and Brain Metastasis, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06159335 is a Phase 3 study of Radiation Therapy and Brain Metastasis that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 30 participants, below the 165-participant average among 7 other Radiation Therapy trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06159335, a Phase 3 study of Radiation Therapy and Brain Metastasis, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to use new imaging methods to help in finding out whether the imaging shows that there is a tumor in people with a brain metastasis. The main question it aims to answer is whether positron emission tomography (PET) and magnetic resonance imaging (MRI) find cancerous tissue better than other types of imagining. Participants will undergo a single PET/MRI scan, followed by a separate MRI scan with a tracer. Study participation will last about 3 hours.
Conditions Studied
Interventions
- RADIATION F-Fluciclovine radiotracer
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-01-10 |
| Est. Completion | 2026-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06159335
The ClinicalTrials.gov registry entry for NCT06159335 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 165-participant average among 7 other Radiation Therapy trials with a reported enrollment target (82% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Radiation Therapy appearing as the primary indexed condition, and to 1 intervention - of which F-Fluciclovine radiotracer is the first listed.
NCT06159335 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06159335 about?
NCT06159335 is a clinical study titled "18F-FLUC PET/MR in Patients With Brain Mets". The goal of this clinical trial is to use new imaging methods to help in finding out whether the imaging shows that there is a tumor in people with a brain metastasis. The main question it aims to answer is whether positron emission tomography (PET) and magnetic resonance imaging (MRI) find cancerou...
What is the current status of trial NCT06159335?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 30 participants. The study started on 2024-01-10. Estimated completion is 2026-06.
What conditions does trial NCT06159335 study?
This clinical trial studies the following conditions: Radiation Therapy, Brain Metastasis, Immunotherapy, Active.
What interventions are being tested in trial NCT06159335?
The interventions under investigation include: F-Fluciclovine radiotracer (RADIATION).
Who is sponsoring clinical trial NCT06159335?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06159335 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiation Therapy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
3D Specimen Maps for RT Planning
RECRUITING
-
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment
RECRUITING
-
Intraoral Hypothermia Device for Preserving Taste During Radiation
RECRUITING · Early Phase 1
-
Activity Coaching During Pelvic Radiation Therapy
RECRUITING · NA
-
Improving Outcomes for Older Adults Undergoing Radiation Therapy
ACTIVE NOT RECRUITING
-
Active Symptom Monitoring in Patients Undergoing Radiation Therapy for Thoracic Malignancies
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.